Dr. Gregory Bailey is a notable leader in the field of longevity research and biotechnology. As a physician, scientist, and entrepreneur, he has demonstrated a strong commitment to advancing scientific understanding and practical applications related to extending human lifespan and promoting healthspan. Dr. Bailey is the co-founder and CEO of Juvenescence, a biotechnology company focused on developing therapies to address age-related diseases and increase longevity. His leadership extends to his involvement in multiple ventures and investments aimed at translating scientific discoveries into tangible solutions for healthy aging. Through his pioneering efforts, Dr. Bailey plays a pivotal role in bridging the gap between cutting-edge research and real-world interventions. His contributions position him as a driving force in the exploration of innovative pathways to enhance the quality of life and extend human lifespan.